Cryptocurrencies
Pfizer Cuts Covid-Drug Outlook – Bad News for This Growth Stock
The decision forced a key supplier for a drug component to reduce 2022 guidance. Pfizer (PFE) – Get Pfizer Inc. Report may have used artificial intelligence and advanced computational modeling to more quickly develop Paxlovid, but Read more…